How Tariff Uncertainty Is Reshaping M&A Deal Structures in 2026

Trade policy has always been a background variable in M&A analysis. In 2026, it has moved to the foreground. The oscillation of U.S. tariff policy through 2025 and into early 2026 has introduced a new category of deal risk, one that dealmakers on both sides of the table are now required to price, manage, and contractually address.

What Changed: From Macro Noise to Deal-Table Risk

For most of the past decade, tariff exposure was something advisors flagged in a risk section and then moved past. The prevailing assumption was that trade friction was manageable, temporary, and largely confined to specific sectors like steel, aluminum, and electronics.

That assumption no longer holds. The re-imposition and expansion of broad tariff schedules in 2025, combined with the unpredictable cadence of exemptions and countermeasures, has made tariff exposure a material line item in deal valuations across manufacturing, industrials, consumer goods, healthcare devices, and technology hardware.

The core problem is not the tariff itself. It is the uncertainty. Buyers building a five-year financial model cannot confidently assign input costs when the tariff schedule on critical components might change between signing and close. Sellers with significant export revenue face similar challenges: the value proposition of their customer relationships may depend on trade terms that no longer exist by the time a buyer assumes ownership.

As major deal advisors have noted in recent 2026 transaction reports, tariff policy has become an external factor that can erode the commercial logic of deals involving U.S.-exposed targets. That is a meaningful shift from treating tariff exposure as a footnote.

How Buyers Are Responding: New Due Diligence Priorities

Sophisticated buyers have updated their diligence checklists to capture tariff exposure in ways that were not standard practice two years ago. The analysis now typically includes a full map of the target's supply chain: country of origin for significant input materials, the applicable tariff classification codes (HTS codes), and the effective duty rates currently being paid. For companies sourcing from China, Southeast Asia, Mexico, or Canada, this analysis can reveal costs not yet reflected in historical financials.

Buyers are also scrutinizing the target's ability to pass through cost increases. A business that absorbs tariff costs without the pricing power to recover them is structurally more exposed than one operating in a market where those costs can be passed downstream. Quality of earnings analysis, already standard on most middle-market transactions, now routinely includes a tariff sensitivity analysis showing how EBITDA would change under various tariff scenarios.

Buyers are additionally examining customer contract terms for pricing reset mechanisms. Long-term supply agreements with fixed pricing become a liability in a rising-tariff environment if the seller cannot renegotiate. Contracts with cost-escalation clauses are increasingly viewed as protective and command attention in diligence.

How Deals Are Being Structured Differently

Perhaps the most visible impact of tariff uncertainty has been at the contract-drafting level. Several structural adaptations have become more common in 2026 transactions.

Tariff-adjustment mechanisms in purchase agreements allow either party to trigger a price renegotiation if tariff rates change materially between signing and close. This is particularly relevant for deals with extended regulatory review periods, where close might come six to twelve months after the letter of intent is signed.

Material Adverse Change (MAC) definitions are being expanded to capture abrupt trade policy shifts. Historically, MAC clauses were drafted narrowly around industry-specific or company-specific events. Buyers are now seeking broader language that captures regulatory or policy changes affecting the target's cost structure or market access. Sellers are pushing back, arguing that broad MAC language creates optionality for buyers to exit deals opportunistically.

Supply chain covenants are also appearing in more agreements. These obligate sellers or target companies to take specific steps before or after closing to reduce tariff exposure: identifying alternative suppliers, qualifying domestic substitutes, or restructuring procurement through lower-tariff jurisdictions.

Earnout structures have increased in frequency. When buyers and sellers cannot agree on a base-case valuation given forward uncertainty, earnouts allow the deal to close at a conservative floor price with upside payments tied to financial performance. For businesses with tariff-affected revenue streams, this bridges a valuation gap that might otherwise kill the transaction.

Valuation Implications: EBITDA Is Only the Starting Point

Tariff exposure affects valuation in ways that go beyond reported EBITDA. In a normalized acquisition analysis, the buyer adjusts historical EBITDA for non-recurring items and then applies a market multiple to arrive at an enterprise value. Tariff-affected costs complicate this at multiple steps.

If a business has been absorbing higher input costs due to tariff increases, its reported EBITDA is already depressed relative to what it would have earned under pre-tariff conditions. A seller will typically argue for an add-back to normalized EBITDA, treating the tariff burden as temporary or mitigable. A buyer will resist, arguing that tariff exposure is the new baseline. This valuation gap is real and is showing up in deal negotiations across affected sectors.

The practical resolution is usually scenario modeling. Buyer and seller agree on a probability-weighted tariff outlook and build two or three cases into the valuation model. The base case reflects the current tariff regime with modest mitigation; the upside case assumes tariff relief; the downside case assumes escalation. The deal price typically reflects the base case, with earnout protection for the upside.

For business owners, the implication is direct: entering a sale process with documented visibility into tariff exposure and a credible mitigation plan supports valuation. Buyers pay more when risk is quantified and managed than when it is vague and unaddressed.

Sectors to Watch Through the Rest of 2026

Tariff impacts are not uniform across industries. Industrial and manufacturing businesses sourcing from China or Southeast Asia face the most direct exposure, particularly for components without ready domestic substitutes. M&A activity in industrials has nonetheless accelerated as private equity firms with operational capabilities acquire tariff-exposed businesses at compressed multiples and invest in supply chain restructuring to realize recovery.

Healthcare device companies with overseas manufacturing are navigating tariff exposure alongside an already complex regulatory environment, resulting in longer diligence timelines and more conservative valuations. Consumer products businesses face pressure on both the input side (imported components) and the demand side (price sensitivity if costs are passed through). Technology hardware companies remain exposed despite some carve-outs in recent tariff schedules.